scorecardresearch
Friday, November 8, 2024
TopicCovid-19 vaccine

Topic: Covid-19 vaccine

Covid vaccine Sputnik V has 91.6% efficacy, Lancet report says. Makers expecting India nod

Kirill Dmitriev, CEO of Russian Direct Investment Fund that makes Sputnik V, also says majority of vaccine doses will be manufactured in India.

Why it takes 2 shots to make mRNA vaccines do the trick

This is what happens to the human body between the first and second dose of an mRNA vaccine.

EU’s U-turn on Covid vaccine exports to UK, and the ‘gutless QAnon party’

The best cartoons of the week, chosen by the editors at ThePrint.

CSIR in talks to bring Moderna’s Covid vaccine to India, says its chief Shekhar Mande

Mande says current talks are scientific, and once CSIR’s Hyderabad-based CCMB understands Moderna’s mRNA technology, it can produce the vaccine ‘within weeks’.

Indian vaccine makers excellent example for lower income countries, Gavi deputy CEO says

Anuradha Gupta, deputy CEO of Gavi, the global vaccine alliance, tells ThePrint India is crucial for the global Covid vaccine response.

Unlike rest of the world, India has plenty of Covid vaccines but few takers

As of 25 January 2021, only about 56% of people eligible to get the shot have stepped forward in a nation with the world’s second-worst Covid-19 outbreak.

Indians must have no confusion about how we reached impressive Covid herd immunity

India’s masses didn’t have the luxury to ‘work from home’ and follow social distancing, but they might have silently built India’s herd immunity.

Adverse events reported in just 0.08% of 15 lakh Covid vaccinations in first week

Most AEFIs reported were minor, such as fever or pain at the injection site. Only 11 people needed to be hospitalised, across six states and capital Delhi.

Why a ‘mucosal’ Covid vaccine has a better shot at ending the pandemic

Novel coronavirus is a pathogen of a ‘mucosal’ organ, different to ‘systemic’ organs. Current vaccines are systemic, and can only reduce disease severity.

How effective are Covid vaccines? Delhi centres to test for antibodies before & after shot

Several institutes and experts advocate see this as an efficacy trial that could help boost confidence in vaccines, especially Bharat Biotech’s Covaxin that is in phase-3 trials.

On Camera

Trump-proofing Europe is a real project. And India can benefit in this

Poland PM Donald Tusk highlighted that the ‘Trump pill’ will serve as a much-needed wake-up call for Europe to make painful but necessary structural changes.

How to Trump-proof India’s trade policy: ‘Give US tariff concessions, block Chinese dumping’

Donald Trump has been vocal about India’s high import tariffs and has threatened retaliation. Simultaneously, his tough stand on China could see Chinese goods flood India.

China unveils J-35A stealth fighter, with striking resemblance to US F-35. Here’s how they compare

The Chinese aircraft has uncanny similarities to the American F-35 jet. There are claims that China copied the design. Cyber theft of F-35 design data was reported in 2009.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.